Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online August 7, 2008
Stem Cells Vol. 26 No. 10 October 2008, pp. 2654 -2663
doi:10.1634/stemcells.2008-0285; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2008-0285v1
26/10/2654    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, A. H.-C.
Right arrow Articles by Chan, A. W.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, A. H.-C.
Right arrow Articles by Chan, A. W.S.

TRANSLATIONAL AND CLINICAL RESEARCH

Putative Dental Pulp-Derived Stem/Stromal Cells Promote Proliferation and Differentiation of Endogenous Neural Cells in the Hippocampus of Mice

Anderson Hsien-Cheng Huanga,b, Brooke R. Snyderc,g, Pei-Hsun Chengc, Anthony W.S. Chancf

aGrace Dental Clinic, Kaohsiung City, Taiwan;
bDepartment of Oral Pathology, School of Dentistry, Kaohsiung Medical University, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;
cYerkes National Primate Research Center,
dDepartment of Human Genetics,
eGenetics and Molecular Biology Program, and
fNeuroscience Program, Emory University School of Medicine, Atlanta, Georgia, USA;
gCenter for Gene Therapy, Tulane University, New Orleans, Louisiana, USA

Key Words. Rhesus monkey • Higher primates • Dental pulp stem/stromal cells • Bone marrow/mesenchymal stem/stromal cells • Cell therapy

Correspondence: Correspondence: Anthony W.S. Chan, D.V.M., Ph.D., Yerkes National Primate Research Center, Rm. 2212 Neuroscience Bldg., 954 Gatewood Rd., N.E., Atlanta, Georgia 30329, USA. Telephone: 404-712-8347; Fax: 404-727-5289; e-mail: achan{at}genetics.emory.edu

Received on April 1, 2008; accepted for publication on July 31, 2008.

First published online in STEM CELLS EXPRESS  August 7, 2008.


Until now, interest in dental pulp stem/stromal cell (DPSC) research has centered on mineralization and tooth repair. Beginning a new paradigm in DPSC research, we grafted undifferentiated, untreated DPSCs into the hippocampus of immune-suppressed mice. The rhesus DPSC (rDPSC) line used was established from the dental pulp of rhesus macaques and found to be similar to human bone marrow/mesenchymal stem cells, which express Nanog, Rex-1, Oct-4, and various cell surface antigens, and have multipotent differentiation capability. Implantation of rDPSCs into the hippocampus of mice stimulated proliferation of endogenous neural cells and resulted in the recruitment of pre-existing Nestin+ neural progenitor cells (NPCs) and β-tubulin-III+ mature neurons to the site of the graft. Additionally, many cells born during the first 7 days after implantation proliferated, forming NPCs and neurons, and, to a lesser extent, underwent astrogliosis, forming astrocytes and microglia, by 30 days after implantation. Although the DPSC graft itself was short term, it had long-term effects by promoting growth factor signaling. Implantation of DPSCs enhanced the expression of ciliary neurotrophic factor, vascular endothelial growth factor, and fibroblast growth factor for up to 30 days after implantation. In conclusion, grafting rDPSCs promotes proliferation, cell recruitment, and maturation of endogenous stem/progenitor cells by modulating the local microenvironment. Our results suggest that DPSCs have a valuable, unique therapeutic potential, specifically as a stimulator and modulator of the local repair response in the central nervous system. DPSCs would be a preferable cell source for therapy due to the possibility of a "personalized" stem cell, avoiding the problems associated with host immune rejection.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.